Cargando…

COVID-19: Where is the treatment?

Even though the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is related to SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), identifying effective and safe therapeutic strategies remains challenging. In search of finding effective treatments to eradicate the virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabeerabi, Bonala, Vemula, Sarojamma, Vadde, Ramakrishna, Nagaraju, Ganji Purnachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173329/ https://www.ncbi.nlm.nih.gov/pubmed/34131563 http://dx.doi.org/10.5306/wjco.v12.i5.309

Ejemplares similares

Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital
por: Sarojamma, Vemula, et al.
Publicado: (2011)

Connective tissue metabolism in chikungunya patients
por: Lokireddy, Sudarsanareddy, et al.
Publicado: (2008)

Genetic predisposition to chikungunya – a blood group study in chikungunya affected families
por: Sudarsanareddy, Lokireddy, et al.
Publicado: (2009)

Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
por: Dariya, Begum, et al.
Publicado: (2020)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

The where and wherefore of evolutionary breakpoints
por: Sankoff, David
Publicado: (2009)

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
por: Ghosn, Marwan, et al.
Publicado: (2016)

Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
por: Lin, Te-Fu, et al.
Publicado: (2018)

Where is the difference between the genomes of humans and annelids?
por: Fedorov, Alexei, et al.
Publicado: (2006)

Where does DNA replication start in archaea?
por: Vas, Amit, et al.
Publicado: (2000)

Beyond BRAF: where next for melanoma therapy?
por: Fedorenko, I V, et al.
Publicado: (2015)

Where does fission yeast sit on the tree of life?
por: Sipiczki, Matthias
Publicado: (2000)

Sessile serrated adenoma/polyps: Where are we at in 2016?
por: Singh, Rajvinder, et al.
Publicado: (2016)

Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy
por: Malla, Rama Rao, et al.
Publicado: (2021)

Apical polarity in three-dimensional culture systems: where to now?
por: Inman, Jamie L, et al.
Publicado: (2010)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Role of endoscopic ultrasound in vascular interventions: Where are we now?
por: Fugazza, Alessandro, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Defining the Pseudomonas Genus: Where Do We Draw the Line with Azotobacter?
por: Özen, Asli I., et al.
Publicado: (2011)

Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?
por: Samo, Salih, et al.
Publicado: (2019)

Extralevator abdominoperineal excision for advanced low rectal cancer: Where to go
por: Tao, Yu, et al.
Publicado: (2020)

Phytochemicals for the treatment of COVID-19
por: Españo, Erica, et al.
Publicado: (2021)

Role of endoscopic ultrasound in liver disease: Where do we stand in 2017?
por: Saraireh, Hamzeh A, et al.
Publicado: (2017)

Circulating tumor DNA: Where are we now? A mini review of the literature
por: Galarza Fortuna, Gliceida Maria, et al.
Publicado: (2020)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects?
por: Maraone, Annalisa, et al.
Publicado: (2021)

Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
por: Galanopoulos, Michail, et al.
Publicado: (2018)

Narrative minireview of the spatial epidemiology of substance use disorder in the United States: Who is at risk and where?
por: Cuadros, Diego F, et al.
Publicado: (2023)

Molecular docking analysis of nuclear factor-κB and genistein interaction in the context of breast cancer
por: Mukund, Vidya, et al.
Publicado: (2019)

Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018)

Liver injury in COVID-19: Detection, pathogenesis, and treatment
por: Cai, Yue, et al.
Publicado: (2021)

Stem cell therapy: A promising treatment for COVID-19
por: Zheng, Zhi-Xue
Publicado: (2021)

Treatment strategies for gastric cancer during the COVID-19 pandemic
por: Kang, Wen-Zhe, et al.
Publicado: (2020)

COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions
por: Triggle, Chris R., et al.
Publicado: (2020)

Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment
por: Qi, Ruo-Bing, et al.
Publicado: (2023)

Critical Roles of Deubiquitinating Enzymes in the Nervous System and Neurodegenerative Disorders
por: Das, Soumyadip, et al.
Publicado: (2020)

Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
por: Fancellu, Alessandro, et al.
Publicado: (2021)

Correction: Exposure to Exogenous Enkephalins Disrupts Reproductive Development in the Eastern Lubber Grasshopper, Romalea microptera (Insecta: Orthoptera)
por: Kumar, Sandeep, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v4mq9022105rm9jpqv2hv63gmc